Albumin Utilization in Adult Cardiac Surgical Patients : A Multicentre Prospective Cohort Study

NCT06395480 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2025-11-26

No results posted yet for this study

Summary

The goal of our proposed multicentre prospective cohort study is to characterize perioperative usage patterns of crystalloids and albumin, as well as key patient outcomes, in cardiac surgical patients. Results obtained from this observational study will be combined with the results of other studies to clarify the optimal role of albumin and other blood products in the perioperative management of cardiac surgical patients. This study will also address numerous other knowledge gaps in the area of perioperative blood product management and fluid administration in cardiac surgery and define a collaborative group to support future research in this field.

Conditions

  • Antithrombin III Levels
  • Albumin Levels

Sponsors & Collaborators

  • Kingston Health Sciences Centre

    collaborator OTHER
  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Keyvan Karkouti, MD MSc FRCPC · Toronto General Hospital - University Health Network

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-11
Primary Completion
2025-12-01
Completion
2026-01-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06395480 on ClinicalTrials.gov